| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ... Autophagy 8 (4), 445-544, 2012 | 5975* | 2012 |
| Hypoxia—a key regulatory factor in tumour growth AL Harris Nature Reviews Cancer 2 (1), 38, 2002 | 4802 | 2002 |
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study C Sotiriou, SY Neo, LM McShane, EL Korn, PM Long, A Jazaeri, P Martiat, ... Proceedings of the National Academy of Sciences 100 (18), 10393-10398, 2003 | 2252 | 2003 |
| Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma CH Lawrie, S Gal, HM Dunlop, B Pushkaran, AP Liggins, K Pulford, ... British journal of haematology 141 (5), 672-675, 2008 | 1860 | 2008 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 1812 | 1998 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 1764 | 2006 |
| The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages KL Talks, H Turley, KC Gatter, PH Maxwell, CW Pugh, PJ Ratcliffe, ... The American journal of pathology 157 (2), 411-421, 2000 | 1436 | 2000 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1277 | 2006 |
| Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma RD Leek, CE Lewis, R Whitehouse, M Greenall, J Clarke, AL Harris Cancer research 56 (20), 4625-4629, 1996 | 1277 | 1996 |
| Increased expression of mutant forms of p53 oncogene in primary lung cancer R Iggo, J Bartek, D Lane, K Gatter, AL Harris The Lancet 335 (8691), 675-679, 1990 | 1249 | 1990 |
| Hypoxia-inducible expression of tumor-associated carbonic anhydrases CC Wykoff, NJP Beasley, PH Watson, KJ Turner, J Pastorek, A Sibtain, ... Cancer research 60 (24), 7075-7083, 2000 | 1242 | 2000 |
| Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth PH Maxwell, GU Dachs, JM Gleadle, LG Nicholls, AL Harris, IJ Stratford, ... Proceedings of the National Academy of Sciences 94 (15), 8104-8109, 1997 | 1177 | 1997 |
| Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial … M Relf, S LeJeune, PAE Scott, S Fox, K Smith, R Leek, A Moghaddam, ... Cancer research 57 (5), 963-969, 1997 | 1060 | 1997 |
| Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer J Richard, C Sainsbury, GK Needham, JR Farndon, AJ Malcolm, ... The Lancet 329 (8547), 1398-1402, 1987 | 1021 | 1987 |
| Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer ER Horak, N Klenk, R Leek, S LeJeune, K Smith, N Stuart, AL Harris, ... The Lancet 340 (8828), 1120-1124, 1992 | 1008 | 1992 |
| Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor RJ Appelhoff, YM Tian, RR Raval, H Turley, AL Harris, CW Pugh, ... Journal of Biological Chemistry 279 (37), 38458-38465, 2004 | 983 | 2004 |
| Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse GJ Bates, SB Fox, C Han, RD Leek, JF Garcia, AL Harris, AH Banham Journal of Clinical Oncology 24 (34), 5373-5380, 2006 | 955 | 2006 |
| Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five … J Baselga, D Rischin, M Ranson, H Calvert, E Raymond, DG Kieback, ... Journal of clinical oncology 20 (21), 4292-4302, 2002 | 948 | 2002 |
| Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials Early Breast Cancer Trialists' Collaborative Group New England Journal of Medicine 333 (22), 1444-1456, 1995 | 945 | 1995 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 941 | 2007 |
Stephen FoxMelbourneDirección de correo verificada de petermac.org
